Evidence map›Paper›PMID 28270126›Full record

ArticleBMC ophthalmology2017

Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.

Sandra Everett, Sahana Vishwanath, Vanessa Cavero, Long Shen, Lakshmanan Suresh, Kishore Malyavantham, Norah Lincoff-Cohen, Julian L Ambrus

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cellular Metabolic Disorders in a Cohort of Patients with Sjogren's Disease.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sandra EverettDepartment of Ophthalmology, SUNY at Buffalo School of Medicine, Buffalo, NY, USA.
Sahana VishwanathDepartment of Medicine, SUNY at Buffalo School of Medicine, Buffalo, NY, USA.
Vanessa CaveroDepartment of Medicine, SUNY at Buffalo School of Medicine, Buffalo, NY, USA.
Long ShenImmco Diagnostics, Buffalo, NY, USA.
Lakshmanan SureshDental School, SUNY at Buffalo School of Medicine, Buffalo, NY, USA.
Kishore MalyavanthamImmco Diagnostics, Buffalo, NY, USA.
Norah Lincoff-CohenDepartment of Ophthalmology, SUNY at Buffalo School of Medicine, Buffalo, NY, USA.
Julian L AmbrusDepartment of Medicine, SUNY at Buffalo School of Medicine, Buffalo, NY, USA. jambrus@buffalo.edu.
University at Buffalo, State University of New York · USIMMCO Diagnostics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDry eye is a common problem in Ophthalmology and may occur for many reasons including Sjogren's syndrome (SS). Recent studies have identified autoantibodies, anti-salivary gland protein 1 (SP1), anti-carbonic anhydrase 6 (CA6) and anti-parotid secretory protein (PSP), which occur early in the course of SS. The current studies were designed to evaluate how many patients with idiopathic dry eye and no evidence of systemic diseases from a dry eye practice have these autoantibodies.

methodsPatients from a dry eye clinic and normal controls were assessed by Schirmer's test for tear flow. Sera were assessed for autoantibodies using ELISA assays. Statistics was performed with Prism 7 software and student's unpaired t test.

resultsIn this study 60% of the dry eye patients expressed one of these autoantibodies. Only 30% expressed one of the autoantibodies associated with long-standing SS, which are included in the diagnostic criteria for SS, anti-Ro and anti-La. Patients with disease for less than 2 years and mild dry eyes did not express anti-Ro or anti-La, while 25% expressed anti-SP1. Similar observations, with smaller numbers, were made when patients had not only dry eye but also dry mouth.

conclusionsAntibodies to SP1, CA6 and PSP occur in some patients with idiopathic dry eyes. Further studies will be needed to determine how many of these patients go on to develop systemic manifestations of SS. Testing for these autoantibodies may allow early recognition of patients with SS. This will lead to improved management of the patients and the development of new strategies to maintain normal lacrimal and salivary gland function in patients with SS.

Indexed as

AdultAgedAged, 80 and overAutoantibodiesBiomarkersCase-Control StudiesDry Eye SyndromesEarly DiagnosisEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulinsMaleMiddle AgedRetrospective StudiesSjogren's SyndromeAutoantibodiesBiomarkersImmunoglobulinsAutoantibodiesCorneal abrasionDry eyesSjogren’s syndrome

Identifiers

PMID28270126
PMCPMC5341407
OpenAlexW2592808296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.